肺中介:一个关于巴克洛芬毒性的病例报告
Fatemeh Zari Meidani1, Rahem Rahmati1, Mojdeh Ghorbankhani2
1Students Research Committee, Shahrekord University of Medical Sciences, Shahrekord, Iran.
International journal of surgery case reports
|October 6, 2023
概括
过量服用巴克洛芬可能会导致罕见的呼吸系统问题,如肺中和肺中症和肺中症. 这些巴克洛芬毒性并发症的早期诊断和管理对于患者的康复至关重要.
科学领域:
- 医学毒理学医学毒理学
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 巴克洛芬是一种GABA激动剂,用于性,但在超过200毫克的剂量时可能有毒.
- 巴克洛芬毒性影响多个器官系统,包括神经和呼吸系统.
- 这一案例突出了与巴克洛芬过量服用相关的罕见呼吸道并发症.
研究的目的:
- 报告一个罕见的巴克洛芬毒性呼吸道并发症病例.
- 突出早期诊断和管理巴克洛芬诱导的呼吸系统问题的重要性.
主要方法:
- 一名19岁的女性在服用巴克洛芬过量后 (500毫克) 呈现.
- 诊断成像显示了肺中和中和肺中和肺中.
- 治疗包括胸腔管和支持性神经医学药物.
主要成果:
- 这位患者出现了肺中和.
- 肺中的治疗是使用胸腔管进行的.
- 患者在四天后成功地被抽管.
结论:
- 高剂量的巴克洛芬可以导致中枢神经系统和呼吸系统抑郁.
- 过量服用巴克洛芬可能会导致支气管 spasms, atelectasis 和 pneumomediastinum.
- 在巴克洛芬中毒中迅速识别呼吸道并发症对于有效的临床管理至关重要.
相关概念视频
Pneumothorax-II
176
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
176
Pneumothorax-I
228
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
228
Skeletal Muscle Relaxants: Adverse Effects
384
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
384
Pleural Effusion II: Symptoms and Management
189
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
189
Acute Respiratory Failure-III
197
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
197
Anticholinesterase Agents: Poisoning and Treatment
896
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
896


